Cargando…

Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects

BACKGROUND AND AIMS: The association of familial hypercholesterolemia (FH) with risk of cardiovascular events (CVE) and death in different cohorts is controversial. We aimed to assess the risk of CVE and death in patients with FH in different cohorts, including CHD and ACS patients, White and Asian,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yani, Chen, Lei, Zhang, Honghong, Fu, Zihao, Liu, Qi, Zhao, Haijing, Liu, Yuqi, Chen, Yundai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253470/ https://www.ncbi.nlm.nih.gov/pubmed/35800161 http://dx.doi.org/10.3389/fcvm.2022.860196

Ejemplares similares

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

CT-Based Leiden Score Outperforms Confirm Score in Predicting Major Adverse Cardiovascular Events for Diabetic Patients with Suspected Coronary Artery Disease
por: Liu, Zinuan, et al.
Publicado: (2022)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
por: Barrios, Vivencio, et al.
Publicado: (2022)

Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia
por: Wang, Yaodong, et al.
Publicado: (2022)

Maternal Hypercholesterolemia May Involve in Preterm Birth
por: Chen, Jingfei, et al.
Publicado: (2022)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Native T1 is predictive of cardiovascular death/heart failure events and all-cause mortality irrespective of the patient’s volume status
por: Treiber, Julia, et al.
Publicado: (2023)

Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects
por: Mahmoud, Ahmed N, et al.
Publicado: (2018)

The Long-Term Impact of Bariatric Surgery on Development of Atrial Fibrillation and Cardiovascular Events in Obese Patients: An Historical Cohort Study
por: Yuan, Hongtao, et al.
Publicado: (2021)

Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective study
por: Li, Dandan, et al.
Publicado: (2019)

Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot
por: Lu, Jiapeng, et al.
Publicado: (2016)

Hypercholesterolemia and Lymphatic Defects: The Chicken or the Egg?
por: Miyazaki, Takuro, et al.
Publicado: (2021)

Applications of machine learning in familial hypercholesterolemia
por: Luo, Ren-Fei, et al.
Publicado: (2023)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Early growth response-1: Key mediators of cell death and novel targets for cardiovascular disease therapy
por: Xie, Yixin, et al.
Publicado: (2023)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Severe Hypercholesterolemia in Very-Low-Carbohydrate Diet
por: Modarressi, Taher
Publicado: (2021)

Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report
por: Feng, Siqin, et al.
Publicado: (2022)

Pregnancy complications and premature cardiovascular events among 1.6 million California pregnancies
por: Arnaout, Rima, et al.
Publicado: (2019)

Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials
por: Wang, Xinyi, et al.
Publicado: (2022)

Motion-compensated T(1) mapping in cardiovascular magnetic resonance imaging: a technical review
por: Sheagren, Calder D., et al.
Publicado: (2023)

Identifying Markers of Cardiovascular Event-Free Survival in Familial Hypercholesterolemia
por: Khoury, Etienne, et al.
Publicado: (2020)

Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia
por: Sarraju, Ashish, et al.
Publicado: (2019)

Diet-Responsive Hypercholesterolemia With Cardiofaciocutaneous Syndrome Type 3
por: Patni, Nivedita, et al.
Publicado: (2021)

Developing a Hybrid Risk Assessment Tool for Familial Hypercholesterolemia: A Machine Learning Study of Chinese Arteriosclerotic Cardiovascular Disease Patients
por: Wang, Lei, et al.
Publicado: (2022)

Commentary: Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: A systematic review and meta-analysis
por: Ke, Yani, et al.
Publicado: (2022)

Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia
por: Xu, Yitong, et al.
Publicado: (2022)

Baseline and Cumulative Blood Pressure in Predicting the Occurrence of Cardiovascular Events
por: Zuo, Yingting, et al.
Publicado: (2021)

SAT-566 Avoiding the Heartache: A Case of Familial Hypercholesterolemia
por: Kinaan, Mustafa, et al.
Publicado: (2020)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
por: Brinck, Jonas, et al.
Publicado: (2022)

Mental health status and risk of new cardiovascular events or death in patients with myocardial infarction: a population-based cohort study
por: Nielsen, Tine Jepsen, et al.
Publicado: (2013)

Non-Contrast Cine Cardiac Magnetic Resonance Derived-Radiomics for the Prediction of Left Ventricular Adverse Remodeling in Patients With ST-Segment Elevation Myocardial Infarction
por: A, Xin, et al.
Publicado: (2023)

SUN-070 Asymptomatic Patients with Homozygous Familial Hypercholesterolemia: A Challenge
por: Lam, Cesar, et al.
Publicado: (2019)

PCSK9 Inhibitors for the Management of Mitotane-Induced Hypercholesterolemia in Adrenocortical Carcinoma
por: Aurora, John A, et al.
Publicado: (2021)

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia
por: Sasaki, Kei, et al.
Publicado: (2022)

Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
por: Kim, Dae Kyu, et al.
Publicado: (2021)

Leukocyte Telomere Length Shortening Implies Plaque Instability and Major Adverse Cardiovascular Events in Patients With Angiographically Intermediate Lesions
por: Zhang, Alian, et al.
Publicado: (2022)

The Association of Stage 1 Hypertension, Defined by the 2017 ACC/AHA Guidelines, With Cardiovascular Events Among Rural Women in Liaoning Province, China
por: Wu, Jiake, et al.
Publicado: (2021)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ft8pj1a2kgk5gbcf1mkf24mbe7